149 related articles for article (PubMed ID: 37794100)
21. Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study.
Fang M; Song H; Zhang J; Li S; Shen D; Tang Y
Pediatr Hematol Oncol; 2021 Oct; 38(7):633-646. PubMed ID: 33724146
[TBL] [Abstract][Full Text] [Related]
22. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
[TBL] [Abstract][Full Text] [Related]
23. Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
Scheinberg P
Hematol Oncol Clin North Am; 2018 Aug; 32(4):609-618. PubMed ID: 30047414
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
Filippidou M; Avgerinou G; Tsipou H; Tourkantoni N; Katsibardi K; Vlachou A; Roka K; Solomou E; Kattamis A
Br J Haematol; 2020 Aug; 190(3):e157-e159. PubMed ID: 32529633
[No Abstract] [Full Text] [Related]
25. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
26. A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
Jin Y; Li R; Lin S; Jia J; Yang Y; Zhang D; He G; Li J
Ann Hematol; 2022 Nov; 101(11):2413-2419. PubMed ID: 36028583
[TBL] [Abstract][Full Text] [Related]
27. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
[TBL] [Abstract][Full Text] [Related]
28. Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia.
Zeng W; Nakao S; Takamatsu H; Yachie A; Takami A; Kondo Y; Sugimori N; Yamazaki H; Miura Y; Shiobara S; Matsuda T
Blood; 1999 May; 93(9):3008-16. PubMed ID: 10216097
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
Afable MG; Shaik M; Sugimoto Y; Elson P; Clemente M; Makishima H; Sekeres MA; Lichtin A; Advani A; Kalaycio M; Tiu RV; O'Keefe CL; Maciejewski JP
Haematologica; 2011 Sep; 96(9):1269-75. PubMed ID: 21606164
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
Risitano AM
Curr Opin Hematol; 2012 Jan; 19(1):3-13. PubMed ID: 22143074
[TBL] [Abstract][Full Text] [Related]
31. Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study.
Scheinberg P; Finelli C; Montaňo-Figueroa EH; Vallejo C; Norasetthada L; Calado RT; Turgut M; Peffault de Latour R; Kriemler-Krahn U; Haenig J; Clark J; Jang J
Lancet Haematol; 2024 Mar; 11(3):e206-e215. PubMed ID: 38335978
[TBL] [Abstract][Full Text] [Related]
32. Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
He G; Zhang X; Wu D; Sun A; Wang X
Pediatr Blood Cancer; 2011 Jul; 56(7):1133-5. PubMed ID: 21488160
[TBL] [Abstract][Full Text] [Related]
33. Relationship between immune status after ATG treatment and PNH clone evolution in patients with severe aplastic anemia.
Wang H; Liu H; Wang T; Li L; Liu C; Li L; Chen T; Qi W; Ding K; Fu R
J Clin Lab Anal; 2021 Mar; 35(3):e23667. PubMed ID: 33249661
[TBL] [Abstract][Full Text] [Related]
34. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.
Scheinberg P; Marte M; Nunez O; Young NS
Haematologica; 2010 Jul; 95(7):1075-80. PubMed ID: 20595102
[TBL] [Abstract][Full Text] [Related]
35. Novel therapeutic choices in immune aplastic anemia.
Scheinberg P
F1000Res; 2020; 9():. PubMed ID: 32953089
[TBL] [Abstract][Full Text] [Related]
36. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
Rosenfeld S; Follmann D; Nunez O; Young NS
JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
[TBL] [Abstract][Full Text] [Related]
37. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
Bacigalupo A; Bruno B; Saracco P; Di Bona E; Locasciulli A; Locatelli F; Gabbas A; Dufour C; Arcese W; Testi G; Broccia G; Carotenuto M; Coser P; Barbui T; Leoni P; Ferster A
Blood; 2000 Mar; 95(6):1931-4. PubMed ID: 10706857
[TBL] [Abstract][Full Text] [Related]
38. [Reference guide for the treatment of aplastic anemia: key points of the 2022 revision].
Yamazaki H
Rinsho Ketsueki; 2023; 64(9):892-899. PubMed ID: 37793863
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of eltrombopag in aplastic anemia: A multi-center survey in China].
Yang WR; Han B; Chang H; Wu BY; Meng FK; Ji DX; Li YM; Zheng ZJ; Fei Y; Shen JP; Hu P; Ding XQ; Zhang P; Wang YQ; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):890-895. PubMed ID: 33333690
[No Abstract] [Full Text] [Related]
40. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
